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The authors conducted a 10-year prospective cohort study of mortality in relation to white blood cell counts of
437,454 Koreans, aged 40–95 years, who received health insurance from the National Health Insurance Corpora-
tion andweremedically evaluated in 1993or 1995, withwhite blood cell measurement. Themain outcomemeasures
were mortality from all causes, all cancers, and all atherosclerotic cardiovascular diseases (ASCVD). Hazard ratios
and 95% conﬁdence intervals were calculated using Cox proportional hazards models with adjustment for age and
potential confounders. During follow-up, 48,757 deaths occurred, with 15,507 deaths from cancer and 11,676 from
ASCVD. For men and women, white blood cell count was associated with all-cause mortality and ASCVD mortality
but not with cancer mortality. In healthy nonsmokers, a graded association between a higher white blood cell count
and a higher risk of ASCVD was observed in men (highest vs. lowest quintile: hazard ratio¼ 2.10, 95% conﬁdence
interval: 1.50, 2.94) and in women (hazard ratio ¼ 1.35, 95% conﬁdence interval: 1.17, 1.56). In healthy smokers,
a graded association between a higher white blood cell count and a higher risk of ASCVDwas also observed in men
(highest vs. lowest quintile: hazard ratio¼ 1.46, 95%conﬁdence interval: 1.25, 1.72). These ﬁndings indicate that the
white blood cell count is an independent risk factor for all-cause mortality and for ASCVD mortality.
arteriosclerosis; cardiovascular diseases; death; leukocytes; neoplasms
Abbreviation: ASCVD, atherosclerotic cardiovascular diseases.
The white blood cell count is an integrated indicator of
inflammatory stimuli on both acute and chronic time frames.
It is elevated acutely by infection and other stresses and
chronically by irritative or toxic exposures, such as tobacco
smoking. Although the white blood cell count is variable
from day to day (1), a single measurement has been shown
to predict risk for death and for specific diseases, including
cancer and cardiovascular diseases (2, 3). Elevation of the
white blood cell count may reflect the underlying disease
process, and white blood cells may play a role in the path-
ogenesis of injury; an elevation of the white blood cell count
may also be a consequence of the development of disease.
Perhaps because of the nonspecificity of the white blood
cell count, it has been shown to predict risk for multiple
diseases.
Several studies over the last three decades have shown
a positive and independent association between white blood
cell count and risk for coronary heart disease (3–8), stroke
(4, 9–11), and all-cause mortality (7, 12–15). These associ-
ations have been found with control for potential confound-
ing by other factors, including smoking and other
cardiovascular risk factors. The white blood cell count has
Correspondence to Dr. Sun Ha Jee, Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University,
Seoul 120-752, Korea (e-mail: jsunha@yumc.yonsei.ac.kr).
1062 Am J Epidemiol 2005;162:1062–1069
American Journal of Epidemiology
Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health
All rights reserved; printed in U.S.A.
Vol. 162, No. 11
DOI: 10.1093/aje/kwi326
Advance Access publication October 12, 2005
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on June 29, 2014
http://aje.oxfordjournals.org/
D
ow
nloaded from
 
also been found to be predictive of mortality from cancer in
some, but not all, studies (7, 16–18). The evidence largely
comes from studies in Western countries, leaving uncer-
tainty as to the generalizability of the findings. The associ-
ation of the white blood cell count with mortality or
morbidity could be different in Asian people, particularly
because Asian men have high smoking rates and women
generally have low smoking rates, less than 5 percent (19).
We are conducting a prospective cohort study of the
causes of cancer in a cohort of 1.3 million Koreans, the
Korean Cancer Prevention Study. The participants were ini-
tially identified by their participation in a routine clinical
examination carried out by the National Health Insurance
Corporation (20). Of the 1.3 million, over 430,000 had
a measurement of white blood cells in 1993 and/or 1995.
In this paper, we address the relation between the level of
white blood cell count and the risk for mortality in this
subgroup of the Korean Cancer Prevention Study.
MATERIALS AND METHODS
Study participants
The Korean Cancer Prevention Study is a cohort study
designed to assess risk factors for mortality and morbidity
from all causes, atherosclerotic cardiovascular diseases
(ASCVD), and cancer, as well as medical morbidity. This
analysis is based on a subset of Korean Cancer Prevention
Study participants having a white blood cell measurement.
The development of this cohort from participants in the
Korea Medical Insurance Corporation has been described
elsewhere (21). In brief, the cohort was selected from gov-
ernment employees, teachers, and their dependents who were
members in 1992–1995, had at least one routine medical
examination, completed a health and lifestyle questionnaire
during that time, and were 30 years of age or older. All in-
sured workers are required to participate in biennial medical
examinations, while their dependents participate on a volun-
tary basis. In 1992, 94 percent of the insured workers com-
pleted the biennial examinations; a total of 95 percent
completed the biennial examinations in 1994. For depen-
dents, the percentages were 37 percent in 1993 and 24 percent
in 1995. In 1993 and 1995 only, a blood sample was obtained
from dependents for measurement of white blood cells.
The full Korean Cancer Prevention Study cohort includes
1,329,525 Koreans (846,907 men and 482,618 women) from
30 to 95 years of age who met the above selection criteria.
Of the study participants, 784,870 (59.0 percent) were en-
rolled in 1992, 367,903 (27.7 percent) in 1993, 98,417 (7.4
percent) in 1994, and 78,335 (5.9 percent) in 1995. Of the
1,329,525 participants, 3,719 who reported a history of any
form of cancer at enrollment and 1,483 who died from can-
cer before the start of follow-up were excluded. We further
excluded the following numbers of participants because of
missing information: 9,619 on alcohol drinking, 17,108 on
fasting serum glucose, and 16,920 on weight or height. The
final sample size for the full Korean Cancer Prevention
Study was 1,283,112. For this analysis, we restricted the
sample to the 438,500 (34.1 percent) for whom the white
blood cell count had been measured.
Data collection
The biennial examinations followed a standard procedure
and were conducted by medical staff at local hospitals. The
completed questionnaires were reviewed and edited by
trained staff and then entered into a database. The data were
edited further before analysis. On the 1992, 1993, 1994, and
1995 questionnaires, participants were asked to describe
their smoking habits, along with other health habits includ-
ing alcohol consumption. Total daily alcohol consumption
was expressed as the number of glasses per week, expressed
in relation to Korea’s most popular alcoholic beverage,
‘‘soju.’’ One glass of soju contains about 12 g of ethanol.
Participants were also asked to report if they exercised reg-
ularly with the question, ‘‘Do you do regular exercise?’’.
The white blood cell counts were quantified by automated
blood cell counters (Beckman Coulter, Fullerton, Califor-
nia) in hospital laboratories, and cell counts are expressed in
Syste`me International d’Unite´s (3 109cells/liter). Differen-
tial white blood cell determinations were not performed.
Fasting serum glucose, total serum cholesterol, and liver
function tests, including alanine aminotransferase and as-
partate aminotransferase, were measured under fasting con-
ditions for routine clinical purposes. Each hospital had
internal and external quality control procedures directed
by the Korean Association of Laboratory Quality Control.
The follow-up period for the full cohort was up to 11
years from January 1, 1993, to December 31, 2003. For this
analysis, follow-up began with the calendar year following
the year during which the white blood cell count was mea-
sured. This approach was followed because the exact dates
of completion of the survey form were not recorded. Con-
sequently, follow-up accrual began on January 1 of the cal-
endar year following the year in which the white blood cell
count was measured and the survey form was completed.
Persons who completed a survey but died within the calen-
dar year of the survey were excluded.
Outcomes
A principal outcome variable was mortality from all
causes from cancer (International Classification of Dis-
eases, Tenth Revision, codes C00–C97) and from ASCVD
(International Classification of Diseases, Tenth Revision,
codes I10–I15, I20, I21, I25, I44–I51, and I60–I74). Out-
comes for mortality were ascertained from the causes of
death listed on death certificates. A computerized search
of death certificate data from the National Statistical Office
in Korea was performed, using the unique identification
number assigned at birth. Causes of death were assigned
at the hospitals by trained abstractors. The first hospitaliza-
tion for ASCVD was also considered as an outcome.
Data analysis
The white blood cell count was categorized as follows:
<5.0, 5.0–5.9, 6.0–6.9, 7.0–7.9, 8.0–8.9, and 9.0 3 109
cells/liter. In all primary analyses, the white blood cell count
category of <5.0 3 109 cells/liter was the referent group.
Age-adjusted death rates were calculated for each category
of white blood cell count level and directly standardized to
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the age distribution of the 1995 Korean national population.
All analyses were stratified by gender and smoking status,
which was described as all smokers, healthy smokers, all
nonsmokers, or healthy nonsmokers. For this stratification,
healthy participants were defined as those without any past
history of diseases reported on the baseline questionnaire.
We computed the hazard ratio (the hazard for mortality in
a specific white blood cell count category divided by the
corresponding hazard in the referent category (<5.0 3
109cells/liter)) using Cox proportional hazards modeling
(22) to adjust for age and other potential confounding fac-
tors. In the Cox model, smoking status was included as
a single dummy variable for ever smokers, with three cate-
gories of amount smoked (1–9, 10–19, and 20 cigarettes
per day), and alcohol use as five categories (none, 1–24, 25–
49, 50–99, and 100 g per day). Effect modification by
gender and smoking was assessed in a model that included
white blood cell count as a continuous variable, and smok-
ing and gender as indicator variables, along with product
terms for white blood cell count with smoking and gender.
RESULTS
Because the white blood cell count was measured only
for participants aged 40 or more years, the age distribution
of participants included in this analysis was older than that
for the Korean Cancer Prevention Study population over-
all and included a greater proportion of women, as the
1993 and 1995 survey participants were primarily women.
The population was mostly middle-aged, with approxi-
mately three times as many women as men (table 1). Par-
ticipants aged 65 years or older comprised 39.1 percent for
men and 17.8 percent for women. The population had
a low body mass index on average, with 20.1 percent of
men and 35.0 percent of women at 25 kg/m2 or above, and
only 0.01 percent of men and 0.03 percent of women
above 30 kg/m2. Both smoking and alcohol use were sub-
stantially more common in men. At baseline, 53.4 percent
and 26.4 percent of 113,421 men and 5.8 percent and 2.9
percent of 324,033 women were current smokers and for-
mer smokers, respectively.
Characteristics by white blood cell count are presented in
table 2. The white blood cell count was positively associated
with body mass index; with the prevalences of hypercholes-
terolemia, hypertension, and diabetes; and with alcohol con-
sumption and smoking. The association of white blood cell
count with age differed in men and women.
During 4,045,287 person-years of follow-up, there were
48,757 deaths, with 15,507 from cancer and 11,676 from
ASCVD, including 2,114 from ischemic heart disease and
8,160 from stroke.
TABLE 1. General characteristics of study participants, Korea, 1993–2003
Characteristic (unit of measure)
Men* Women*
Nonsmokers
(mean (SDy) or %)
Smokers
(mean (SD) or %)
Nonsmokers
(mean (SD) or %)
Smokers
(mean (SD) or %)
Age (years) 62.6 (9.1) 62.3 (8.4) 53.9 (9.7) 63.9 (9.8)
White blood cell count (3 109 cells/liter) 6.8 (1.7) 7.3 (1.9) 6.5 (1.6) 7.0 (1.8)
Body mass index (kg/m2) 23.2 (2.9) 22.4 (2.9) 24.0 (3.1) 23.0 (3.5)
Total cholesterol (mg/dl) 190.3 (38.4) 190.2 (39.0) 199.2 (39.5) 205.8 (40.9)
Systolic blood pressure (mmHg) 131.2 (21.3) 129.1 (20.9) 125.5 (20.8) 127.0 (22.0)
Fasting blood sugar (mg/dl) 98.8 (36.0) 96.3 (32.3) 92.9 (26.7) 95.2 (32.0)
Obesityz 26.8 18.4 35.8 27.1
Hypercholesterolemiaz 9.9 9.9 14.7 19.1
Hypertensionz 50.0 45.9 38.2 41.3
Diabetesz 9.2 7.8 5.0 6.8
Alcohol drinking 46.7 65.0 11.9 31.4
Exercise 33.9 28.9 18.2 17.0
Cigarette smoking 91.3
Nonsmokers 20.2
Former smokers 26.4 2.9
Current smokers
1–9 cigarettes per day 15.9 3.2
10–19 cigarettes per day 21.8 1.9
20 cigarettes per day 15.7 0.7
* Male nonsmokers: n ¼ 22,908; male smokers: n ¼ 90,513; female nonsmokers: n ¼ 295,807; female smokers: n ¼ 28,226.
y SD, standard deviation.
z Obesity: 25 kg/m2; hypercholesterolemia: 240 mg/dl; hypertension: systolic blood pressure, 140 mmHg, or diastolic blood pressure,
90 mmHg, or medication; diabetes: fasting blood sugar, 126 mg/dl, or medication.
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Table 3 provides the hazard ratios for mortality among
men by smoking and reported disease status on entry.
The white blood cell count was associated with all-cause
mortality only in the two highest strata, and the hazard
ratios were greater in nonsmokers than in smokers. The
white blood cell count was not associated with risk for
death from cancer, but it was positively associated with
risk for ASCVD death. There was a progressive rise in
the hazard ratios for ASCVD death with increasing white
blood cell count. In women, the patterns were similar, but
the effect of white blood cell count was lower for ASCVD
(table 4).
We next formally tested for effect modification of the risk
of mortality associated with white blood cell count by gen-
der and smoking, using white blood cell count as a continu-
ous variable. For total mortality and for ASCVD, there were
significant interactions of white blood cell count with gen-
der, males having greater risk with increasing white blood
cell count than females, and with smoking, nonsmokers
having greater risk with increasing white blood cell count
than smokers. For cancer mortality, these interactions were
not significant (data not shown).
We further explored patterns of association of white blood
cell count with ASCVD for the two major categories, coro-
nary heart disease and stroke (figures 1, 2, 3, and 4). Figures 1
through 4 provide hazard ratios for death from coronary heart
disease and stroke for men and women by cigarette smoking
status. While the risk for death tends to rise with white blood
cell count in both sexes, the gradient is much steeper in men.
Among the men, the effect of white blood cell count was
greater among nonsmokers than smokers.
DISCUSSION
In this large cohort study of Korean men and women, we
documented that the white blood cell count predicts mortal-
ity from all causes and from ASCVD in men and women.
The white blood cell count was not associated with risk for
death from cancer. We found effect modification by smok-
ing status and gender that varied across the major categories
of death that we considered.
Perhaps because it is readily and accurately measured,
white blood cell count has been examined by many studies
as a predictor of all-cause mortality and of mortality from
specific diseases. The white blood cell count has also been
assessed as a predictor of outcome following disease onset,
for example, after myocardial infarction (23, 24). The white
blood cell count is plausibly a predictor of mortality risk and
disease prognosis, because it broadly indicates the level of
host response to stressors and provides an index of acute and
chronic inflammatory processes (3, 25). The white blood
cell count is highly variable, however, as it is responsive
to diverse acute stimuli. Nonetheless, a single white blood
cell count has been associated with a variety of long-term
health risks (25).
TABLE 2. Characteristics of cohort members by white blood cell count, Korean men and women,
1993–2003
White blood cell count, 3 109 cells/liter
<5.0 5.0–5.9 6.0–6.9 7.0–7.9 8.0–8.9 9.0
Men (no.) 8,437 20,266 27,565 24,364 15,609 17,180
Elderly* (%) 44.3 41.5 40.5 39.3 38.3 36.0
Obesity* (%) 14.0 18.5 20.0 21.5 22.0 21.4
Hypercholesterolemia* (%) 6.4 8.3 9.3 10.5 10.8 12.7
Hypertension* (%) 42.2 45.3 46.7 48.3 47.6 47.7
Diabetes* (%) 7.7 7.2 8.0 8.0 8.3 9.4
Cigarette smoking (%) 71.5 75.7 78.5 80.8 83.0 86.4
Alcohol drinking (%) 57.3 59.5 61.2 62.1 62.6 63.1
Exercise (%) 32.6 31.6 30.9 29.4 28.8 26.7
Women (no.) 45,589 81,434 84,073 57,766 30,441 24,730
Elderly* (%) 14.1 16.1 17.5 19.1 20.6 23.9
Obesity* (%) 26.3 31.9 35.8 38.8 40.3 42.4
Hypercholesterolemia* (%) 11.1 13.3 15.1 16.6 17.9 21.0
Hypertension* (%) 32.2 36.0 38.9 40.9 43.0 44.7
Diabetes* (%) 3.0 3.8 4.9 6.1 7.1 9.3
Cigarette smoking (%) 5.6 7.1 8.5 9.9 11.3 14.8
Alcohol drinking (%) 11.6 13.0 13.7 14.3 15.0 15.4
Exercise (%) 18.9 18.5 18.2 17.7 17.2 16.3
* Elderly: 65 years; obesity: 25 kg/m2; hypercholesterolemia: 240 mg/dl; hypertension: systolic blood
pressure, 140 mmHg, or diastolic blood pressure, 90 mmHg, or medication; diabetes: fasting blood sugar, 126
mg/dl, or medication.
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For total mortality, the present study showed that the
white blood cell count predicted all-cause mortality, an as-
sociation previously observed in middle-aged populations
(7, 10) and in elderly men (15). Although the association
between white blood cell count and all-cause mortality re-
mained after excluding participants with a clinical diagnosis
of major chronic diseases on entry, underlying disease on
enrollment may have affected the observed association.
TABLE 3. Hazard ratios* (95% conﬁdence intervals) of white blood cell count for death from all causes, all cancers, and all
atherosclerotic cardiovascular diseases in Korean men, 1993–2003
White blood cell count, 3 109 cells/liter
<5.0 5.0–5.9 6.0–6.9 7.0–7.9 8.0–8.9 9.0
All deaths (no. of cases)
All smokers (n ¼ 22,033) 1.0 0.94 (0.89, 1.00) 0.95 (0.90, 1.00) 0.99 (0.93, 1.05) 1.01 (0.95, 1.07) 1.14 (1.07, 1.21)
Healthy smokers (n ¼ 18,169) 1.0 0.96 (0.89, 1.02) 0.95 (0.89, 1.01) 1.00 (0.94, 1.07) 1.01 (0.95, 1.09) 1.15 (1.08, 1.23)
All nonsmokers (n ¼ 4,488) 1.0 0.96 (0.86, 1.07) 0.97 (0.87, 1.08) 1.05 (0.94, 1.18) 1.20 (1.06, 1.36) 1.38 (1.22, 1.56)
Healthy nonsmokers (n ¼ 3,877) 1.0 1.00 (0.88, 1.13) 1.01 (0.90, 1.14) 1.10 (0.97, 1.24) 1.27 (1.12, 1.46) 1.40 (1.22, 1.60)
All cancers (no. of cases)
All smokers (n ¼ 8,112) 1.0 0.90 (0.82, 0.99) 0.87 (0.80, 0.96) 0.88 (0.80, 0.97) 0.89 (0.80, 0.98) 1.00 (0.90, 1.09)
Healthy smokers (n ¼ 6,787) 1.0 0.91 (0.82, 1.01) 0.86 (0.78, 0.96) 0.92 (0.83, 1.01) 0.89 (0.80, 1.00) 1.00 (0.90, 1.11)
All nonsmokers (n ¼ 1,280) 1.0 0.80 (0.65, 0.97) 0.78 (0.65, 0.95) 0.81 (0.67, 0.99) 0.97 (0.78, 1.20) 0.92 (0.74, 1.16)
Healthy nonsmokers (n ¼ 1,136) 1.0 0.86 (0.70, 1.07) 0.86 (0.70, 1.06) 0.86 (0.69, 1.06) 1.06 (0.84, 1.33) 0.94 (0.73, 1.20)
All ASCVDy (no. of cases)
All smokers (n ¼ 4,301) 1.0 1.13 (0.97, 1.31) 1.20 (1.04, 1.38) 1.27 (1.10, 1.46) 1.35 (1.16, 1.57) 1.44 (1.25, 1.67)
Healthy smokers (n ¼ 3,571) 1.0 1.11 (0.94, 1.30) 1.19 (1.02, 1.39) 1.24 (1.06, 1.45) 1.30 (1.10, 1.53) 1.46 (1.25, 1.72)
All nonsmokers (n ¼ 983) 1.0 1.48 (1.10, 2.00) 1.76 (1.32, 2.35) 1.99 (1.49, 2.66) 2.26 (1.67, 3.07) 2.33 (1.71, 3.17)
Healthy nonsmokers (n ¼ 831) 1.0 1.38 (1.01, 1.90) 1.65 (1.22, 2.25) 1.84 (1.35, 2.51) 2.14 (1.54, 2.97) 2.10 (1.50, 2.94)
* Adjusted for age, age2, obesity, hypercholesterolemia, hypertension, diabetes, alcohol drinking, exercise, and amount of smoking for
smokers only.
y ASCVD, atherosclerotic cardiovascular diseases.
TABLE 4. Hazard ratios* (95% conﬁdence intervals) of white blood cell count for death from all causes, all cancers, and all
atherosclerotic cardiovascular diseases in Korean women, 1993–2003
White blood cell count, 3 109 cells/liter
<5.0 5.0–5.9 6.0–6.9 7.0–7.9 8.0–8.9 9.0
All deaths (no. of cases)
All smokers (n ¼ 5,340) 1.0 0.89 (0.80, 1.01) 0.98 (0.88, 1.09) 0.98 (0.88, 1.10) 1.03 (0.91, 1.16) 1.26 (1.12, 1.41)
Healthy smokers (n ¼ 4,562) 1.0 0.90 (0.80, 1.02) 0.97 (0.86, 1.09) 0.98 (0.87, 1.10) 1.05 (0.92, 1.19) 1.28 (1.13, 1.46)
All nonsmokers (n ¼ 16,896) 1.0 0.89 (0.84, 0.94) 0.93 (0.89, 0.98) 0.97 (0.92, 1.03) 1.00 (0.94, 1.06) 1.20 (0.94, 1.06)
Healthy nonsmokers (n ¼ 14,072) 1.0 0.91 (0.86, 0.97) 0.97 (0.92, 1.02) 1.00 (0.94, 1.06) 1.02 (0.95, 1.10) 1.21 (1.13, 1.30)
All cancers (no. of cases)
All smokers (n ¼ 1,139) 1.0 0.85 (0.67, 1.07) 0.89 (0.72, 1.11) 0.73 (0.58, 0.92) 0.80 (0.62, 1.03) 0.99 (0.78, 1.25)
Healthy smokers (n ¼ 976) 1.0 0.87 (0.68, 1.12) 0.92 (0.73, 1.17) 0.76 (0.59, 0.98) 0.87 (0.66, 1.14) 1.08 (0.83, 1.40)
All nonsmokers (n ¼ 4,976) 1.0 0.83 (0.76, 0.91) 0.81 (0.74, 0.88) 0.91 (0.83, 1.00) 0.79 (0.70, 0.89) 0.95 (0.84, 1.07)
Healthy nonsmokers (n ¼ 4,252) 1.0 0.88 (0.80, 1.00) 0.87 (0.78, 0.95) 0.96 (0.87, 1.07) 0.83 (0.73, 0.95) 0.98 (0.86, 1.12)
All ASCVDy (no. of cases)
All smokers (n ¼ 1,419) 1.0 0.95 (0.76, 1.19) 1.06 (0.86, 1.32) 1.11 (0.89, 1.38) 1.17 (0.92, 1.48) 1.20 (0.95, 1.52)
Healthy smokers (n ¼ 1,217) 1.0 0.95 (0.76, 1.19) 1.02 (0.81, 1.28) 1.11 (0.88, 1.41) 1.14 (0.88, 1.47) 1.21 (0.94, 1.56)
All nonsmokers (n ¼ 4,284) 1.0 1.04 (0.93, 1.17) 1.17 (1.05, 1.31) 1.21 (1.08, 1.36) 1.30 (1.15, 1.48) 1.34 (1.17, 1.53)
Healthy nonsmokers (n ¼ 3,565) 1.0 1.05 (0.92, 1.19) 1.20 (1.06, 1.35) 1.23 (1.09, 1.40) 1.33 (1.16, 1.53) 1.35 (1.17, 1.56)
* Adjusted for age, age2, obesity, hypercholesterolemia, hypertension, diabetes, alcohol drinking, exercise, and amount of smoking for
smokers only.
y ASCVD, atherosclerotic cardiovascular diseases.
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Inflammation is currently considered to play a central role
in carcinogenesis, a hypothesis that has been addressed by
assessing white blood cell count as a predictor of risk for
cancer. In a 1985 analysis of data from the Multiple Risk
Factor Intervention Trial (MRFIT), Grimm et al. (7) found
that the white blood cell count was significantly associated
with risk for cancer death. In a study of Kaiser Permanente
participants, Friedman and Fireman (18) found that the
white blood cell count was associated with mortality from
all cancers, cancers caused by smoking, and cancers not
caused by smoking, but it was not associated with cancer
mortality in nonsmokers. Most recently, Erlinger et al. (16)
reported an association of white blood cell count with total
cancer mortality using the follow-up of the participants in
the Second National Health and Nutrition Examination
Survey (NHANES II). By contrast, in a much larger cohort,
we did not find evidence supporting an association of white
blood cell count with cancer mortality in either smokers or
nonsmokers.
For cardiovascular diseases, the white blood cell count
has been assessed as both a predictor of risk for incident
disease and a prognostic indicator following ischemic
events and myocardial infarction (3). Ernst et al. (26) sug-
gest that white blood cells may be involved in vascular
injury through 1) pressure-dependent plugging of microves-
sels, 2) rheologic properties such as altered deformability
and the formation of aggregates when provoked by a variety
of stimuli, and 3) increased leukocyte adhesiveness and re-
lease of substances resulting in cytotoxic injury to endothe-
lial cells. In a recent review, Madjid et al. (3) summarized
the results of 15 studies of white blood cell count and risk
for coronary heart disease in persons without disease on
enrollment. In nearly all studies, the white blood cell count
was associated with increased risk. A meta-analysis pub-
lished in 1998 showed an overall risk ratio of 1.5 (95 percent
confidence interval: 1.4, 1.6), comparing the highest with
the lowest stratum of white blood cell count in participants
in 19 prospective studies. The risks observed in the present
study were in the range, that is, up to 2, covered in previous
studies (6).
For stroke, the white blood cell count was associated with
ischemic stroke in a previous prospective cohort study of
FIGURE 1. Hazard ratios and 95% conﬁdence intervals of white
blood cell count for coronary heart disease in nonsmoking Korean
men, 1993–2003. WBC, white blood cell. Values in parentheses
denote numbers of cases.
FIGURE 4. Hazard ratios and 95% conﬁdence intervals of white
blood cell count for stroke in nonsmoking Korean women, 1993–2003.
WBC, white blood cell. Values in parentheses denote numbers of
cases.
FIGURE 3. Hazard ratios and 95% conﬁdence intervals of white
blood cell count for stroke in nonsmoking Korean men, 1993–2003.
WBC, white blood cell. Values in parentheses denote numbers of
cases.
FIGURE 2. Hazard ratios and 95% conﬁdence intervals of white
blood cell count for coronary heart disease in nonsmoking Korean
women, 1993–2003. WBC, white blood cell. Values in parentheses
denote numbers of cases.
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atomic bomb survivors, but potential confounding by smok-
ing was not explored (27). In a prospective study of US
adults, Gillum et al. (10) found the white blood cell count
to be weakly associated with stroke, but not after adjustment
for smoking. The risk factors associated with stroke are
different in younger and older subjects. In an 8-year follow-
up study in southern Italy, the researchers suggested that
the white blood cell count may have a relevant role at least
in the elderly (28). However, they did not adjust smoking
status. In the present study, the white blood cell count was
associated with increased risk of stroke in male nonsmokers,
but there was only a weak association in women.
Smoking increases the white blood cell count by an av-
erage of about 1,000 cells per ml, and the white blood cell
count increases with the amount smoked (29). Thus, in
smokers, the white blood cell count may be a useful bio-
marker of inflammation caused by smoking. We found,
however, that the white blood cell count tended to be a stron-
ger predictor in nonsmokers, in comparison with smokers
(tables 3 and 4; figures 1, 2, 3, and 4). Our finding of strong
associations among never smokers suggests that a higher
white blood cell count is an independent risk factor for
ASCVD, confirming findings from other studies on white
blood cell count and ASCVD in nonsmokers (4, 5, 11, 15).
The potential limitations of our study arise primarily from
the use of data collected as part of an insurance plan. The
questionnaires provide self-reported smoking and alcohol
use information without validation, and death certificate
attribution of cause of death to cancer and ASCVD is sub-
ject to misclassification (7). While we are uncertain if these
findings apply to cancer generally and to cardiovascular
diseases, a pilot study on coding of lung cancer deaths
showed high concordance between death certificate and
clinical information (9). While the white blood cell count
can be conceptualized as a mixed marker of exposure and
response, the validity of using a single white blood cell
count as a biomarker is still questionable. The coefficient
of variation for the measurement of total white blood cell
count in the blood is low, in the 1–2 percent range with
established automated methods (30). In the present study,
the correlation of white blood cell counts in 1993 and 1995
for participants having repeated measurements was 0.45.
Additionally, our study cohort is not broadly representative
of Koreans, as it is limited to employed persons and their
families. This analysis was limited to a subgroup of the full
cohort, but the selection process for having a white blood
cell measurement should not have led to any bias.
Cigarette smoking produces substantial, chronic eleva-
tions in the white blood cell count (7) and is a cause of
cardiovascular disease. Therefore, confounding by smoking
is a concern. To address this issue, we performed analyses
stratified by smoking status. The association between white
blood cell count and death from cardiovascular disease
strengthened when the analysis was restricted to men who
had never smoked. The hazard ratio of all cardiovascular
disease death, when comparing the highest versus the lowest
quintile, was higher in healthy nonsmokers than in healthy
smokers. In conclusion, our results indicate an association
of white blood cell count with all-cause mortality and
ASCVD mortality, independent of smoking.
ACKNOWLEDGMENTS
This study was funded by the National Cancer Institute
of the National Institutes of Health, US Department of
Health and Human Services (1RO3 CA94771-02).
The authors thank the staff of the Korean National Health
Insurance Corporation.
Conflict of interest: none declared.
REFERENCES
1. Pocock SJ, Ashby D, Shaper AG, et al. Diurnal variations in
serum biochemical and hematological measurements. J Clin
Pathol 1989;42:172–9.
2. Hoffman M, Blum A, Baruch R, et al. Leukocytes and coro-
nary heart disease. Atherosclerosis 2004;172:1–6.
3. Madjid M, Awan I, Willerson JT, et al. Leukocyte count and
coronary heart disease: implications for risk assessment. J Am
Coll Cardiol 2004;44:1945–56.
4. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count
and incidence of coronary heart disease and ischemic stroke
and mortality from cardiovascular disease in African-
American and White men and women: Atherosclerosis Risk
in Communities Study. Am J Epidemiol 2001;154:758–64.
5. Brown DW, Giles WH, Croft JB. White blood cell count: an
independent predictor of coronary heart disease mortality
among a national cohort. J Clin Epidemiol 2001;54:316–22.
6. Danesh J, Collins R, Appleby P, et al. Association of fibrino-
gen, C-reactive protein, albumin, or leukocyte count with
coronary heart disease: meta-analyses of prospective studies.
JAMA 1998;279:1477–82.
7. Grimm RH, Neaton JD, Ludwig W. Prognostic importance of
the white blood cell count for coronary, cancer, and all-cause
mortality. JAMA 1985;254:1932–7.
8. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte
count as a predictor of myocardial infarction. N Engl J Med
1974;290:1275–8.
9. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study
of markers of hemostatic function with risk of ischemic stroke.
The Atherosclerosis Risk in Communities (ARIC) Study In-
vestigators. Circulation 1999;100:736–42.
10. Gillum RF, Ingram DD, Makuc DM. White blood cell count
and stroke incidence and death. The NHANES I Epidemio-
logic Follow-up Study. Am J Epidemiol 1994;139:894–902.
11. Kannel WB, Anderson K, Wilson PWF. White blood cell
count and cardiovascular disease. Insights from the Framing-
ham Study. JAMA 1992;267:1253–6.
12. Izaks GJ, Remarque EJ, Becker SV, et al. Lymphocyte count
and mortality risk in older persons. The Leiden 85-Plus Study.
J Am Geriatr Soc 2003;51:1461–5.
13. James AL, Knuiman MW, Divitini ML, et al. Associations
between white blood cell count, lung function, respiratory
illness and mortality: the Busselton Health Study. Eur Respir
J 1999;13:1115–19.
14. de Labry LO, Campion EW, Glynn RJ, et al. White blood cell
count as a predictor of mortality: results over 18 years from the
Normative Aging Study. J Clin Epidemiol 1990;43:153–7.
15. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell
count and the risk of coronary heart disease and all-cause
mortality in elderly men. Arterioscler Thromb Vasc Biol
1996;16:499–503.
16. Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and
the risk of cancer mortality in a national sample of U.S.
1068 Jee et al.
Am J Epidemiol 2005;162:1062–1069
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on June 29, 2014
http://aje.oxfordjournals.org/
D
ow
nloaded from
 
adults: results from the Second National Health and Nutrition
Examination Survey Mortality Study. Cancer Epidemiol Bio-
markers Prev 2004;13:1052–6.
17. Phillips AN, Neaton JD, Cook DG, et al. The leukocyte
count and risk of lung cancer. Cancer 1992;69:680–4.
18. Friedman GD, Fireman BH. The leukocyte count and cancer
mortality. Am J Epidemiol 1991;133:376–80.
19. Gallup Korea. Cigarette smoking survey among adults. Seoul,
South Korea: The Korea Gallup Report, 2004.
20. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level
and cancer risk in Korean men and women. JAMA 2005;293:
194–202.
21. Jee SH, Samet JM, Ohrr H, et al. Smoking and cancer risk in
Korean men and women. Cancer Causes Control 2004;15:
341–8.
22. Cox DR. Regression models and life tables. J R Stat Soc (B)
1972;34:187–202.
23. Hung MJ, Cherng WJ. Comparison of white blood cell counts
in acute myocardial infarction patients with significant versus
insignificant coronary artery disease. Am J Cardiol 2003;91:
1339–42.
24. Cannon CP, McCabe CH, Wilcox RG, et al. Association of
white blood cell count with increased mortality in acute
myocardial infarction and unstable angina pectoris. OPUS-
TIMI 16 Investigators. Am J Cardiol 2001;87:636–9, A10.
25. Crowell RJ, Samet JM. Invited commentary: why does the
white blood cell count predict mortality? Am J Epidemiol
1995;142:499–501.
26. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and
the risk of ischemic diseases. JAMA 1987;257:2318–24.
27. Prentice RL, Szatrowski TP, Kato H, et al. Leukocyte counts
and cerebrovascular disease. J Chronic Dis 1982;35:703–14.
28. Noto D, Barbagallo CM, Cavera G, et al. Leukocyte count,
diabetes mellitus and age are strong predictors of stroke in
a rural population in southern Italy: an 8-year follow-up.
Atherosclerosis 2001;157:225–31.
29. US Department of Health and Human Services. The health
effects of active smoking: a report of the Surgeon General.
Washington, DC: US Government Printing Office, 2004.
30. Bollinger PB, Drewenko B, Brailas CD. The Technicon H-1:
an automated hematology analyzer for today and tomorrow.
Am J Clin Pathol 1987;87:71–6.
White Blood Cell Count and Mortality 1069
Am J Epidemiol 2005;162:1062–1069
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on June 29, 2014
http://aje.oxfordjournals.org/
D
ow
nloaded from
 
